Related Experiment Video
Updated: Aug 26, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis
1Department of Hygiene, Technical University, 8000 Munich, FRG.
Insights
Cefadroxil demonstrated superior efficacy over phenoxymethyl-penicillin in treating acute tonsillopharyngitis caused by group A streptococci in children. Cefadroxil achieved significantly lower microbiological failure rates, indicating better treatment outcomes.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Acute tonsillopharyngitis is a common childhood illness.
- Group A streptococci are a primary bacterial cause of acute tonsillopharyngitis.
- Phenoxymethyl-penicillin has been a standard treatment, but resistance and efficacy concerns exist.
Purpose of the Study:
- To compare the efficacy of cefadroxil and phenoxymethyl-penicillin in treating group A streptococcal tonsillopharyngitis.
- To evaluate microbiological and clinical failure rates between the two antibiotic treatments.
- To assess the impact of beta-lactamase producing staphylococci on treatment outcomes.
Main Methods:
- A randomized multicenter study involving 300 children with suspected streptococcal tonsillopharyngitis.
- Patients were treated with either phenoxymethyl-penicillin or cefadroxil.
- Microbiological and clinical assessments were performed after ten days of therapy.
Main Results:
- Cefadroxil showed a significantly lower microbiological failure rate (6.8%) compared to phenoxymethyl-penicillin (19%) (p<0.01).
- Fewer patients treated with cefadroxil experienced clinical symptoms alongside microbiological failure.
- The presence of beta-lactamase producing staphylococci was associated with higher failure rates in the penicillin group.
Conclusions:
- Cefadroxil is clinically and bacteriologically superior to phenoxymethyl-penicillin for treating acute tonsillopharyngitis caused by group A streptococci.
- Antibiotic choice should consider local flora, including beta-lactamase producing organisms.
- Cefadroxil represents a more effective therapeutic option for this common pediatric infection.
Abstract:
In a randomized multicentre study the efficacy of phenoxymethyl-penicillin and cefadroxil was tested in the treatment of acute tonsillopharyngitis caused by group A streptococci. These organisms were detected in 269 of the 300 children studied. Of the 239 patients in whom results could be evaluated, 121 received penicillin and 118 cefadroxil. After ten days of therapy the microbiological failure rate was 19% in the penicillin group and 6.8% in the cefadroxil group (p less than 0.01). Ten of 23 cases of microbiological failure in the penicillin group and two of eight in the cefadroxil group also had clinical symptoms of infection. All streptococcal isolates were sensitive to penicillin, cefadroxil and clindamycin with the exception of one strain with intermediate sensitivity to cefadroxil. Seven strains had intermediate sensitivity to erythromycin and one was resistant. No penicillin tolerance was observed. Patients in whom penicillin therapy failed more frequently had beta-lactamase producing staphylococci in the pharyngeal flora in comparison to successfully treated patients. The clinical and bacteriological results showed that cefadroxil was clearly superior to penicillin.
More Related Videos
Related Concept Videos
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Production of Antibiotics
Streptococcal Pharyngitis
Inhibitors of Gram-positive Cell Wall Synthesis

